论文部分内容阅读
目的:探讨依达拉奉在治疗急性脑梗塞中的疗效及临床价值。方法:将我院近期收治的100例患者随机分为观察组和对照组各50例,对照组采用常规治疗,观察组在常规治疗的基础上使用依达拉奉治疗。结果:观察组在神经功能缺损评分方面明显优于对照组,差异具有统计学意义(P<0.05)。两组在给药期间均未发生严重的不良反应。结论:依达拉奉治疗急性脑梗塞患者临床疗效显著,值得临床推广。
Objective: To investigate the efficacy and clinical value of edaravone in the treatment of acute cerebral infarction. Methods: A total of 100 patients admitted to our hospital were randomly divided into observation group (50 cases) and control group (50 cases). The control group was treated with conventional therapy. The observation group was treated with edaravone on the basis of routine treatment. Results: The observation group was significantly better than the control group in neurological deficit score, the difference was statistically significant (P <0.05). No adverse reactions occurred in both groups during the administration. Conclusion: Edaravone has a significant clinical effect in the treatment of acute cerebral infarction and is worthy of clinical promotion.